Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies.
Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, Mfinanga S, Kapata N, Mwaba P, McHugh TD, Ippolito G, Migliori GB, Maeurer MJ, Zumla A.
Tiberi S, et al. Among authors: kapata n.
Lancet Infect Dis. 2018 Jul;18(7):e183-e198. doi: 10.1016/S1473-3099(18)30110-5. Epub 2018 Mar 23.
Lancet Infect Dis. 2018.
PMID: 29580819
Review.